HLB Life Science Co., Ltd. (KOSDAQ:A067630) agreed to acquire 14% stake in HLB Co., Ltd. from Jinyanggon, Hyuna Lee, Hyunsoo Lee, Alex S. Kim, Yongwoong Kim and Coughing season on November 5, 2019.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,950 KRW | -3.03% | +1.19% | +48.03% |
Mar. 22 | HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% | MT |
Mar. 21 | HLB Life Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+48.03% | 1.32B | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B |
- Stock Market
- Equities
- A067630 Stock
- News HLB Life Science Co., Ltd.
- HLB Life Science Co., Ltd. agreed to acquire 14% stake in HLB Co., Ltd. from Jinyanggon, Hyuna Lee, Hyunsoo Lee, Alex S. Kim, Yongwoong Kim and Coughing season.